These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 36324078)
21. [Respiratory failure can be seen in chronic inflammatory demyelinating polyneuropathy: a case report]. Christani M Lakartidningen; 2022 Feb; 119():. PubMed ID: 35147209 [TBL] [Abstract][Full Text] [Related]
32. Nerve Ultrasound and Electrophysiology for Therapy Monitoring in Chronic Inflammatory Demyelinating Polyneuropathy. Kerasnoudis A; Pitarokoili K; Gold R; Yoon MS J Neuroimaging; 2015; 25(6):931-9. PubMed ID: 26242571 [TBL] [Abstract][Full Text] [Related]
33. [Clinical and long-term characteristics of the subtypes of chronic inflammatory demyelinating polyneuropathy]. Shimizu F; Nemoto J; Takeshita Y; Maeda T; Koga M; Kanda T Rinsho Shinkeigaku; 2022 Mar; 62(3):173-177. PubMed ID: 35228460 [TBL] [Abstract][Full Text] [Related]
34. Serum neurofilament light chain does not detect self-reported treatment-related fluctuations in chronic inflammatory demyelinating polyneuropathy. Poser PL; Sajid GS; Beyer L; Hieke A; Schumacher A; Horstkemper L; Karl AS; Grüter T; Sgodzai M; Pitarokoili K; Gerwert K; Gold R; Fisse AL; Gisevius B; Motte J Eur J Neurol; 2024 Jan; 31(1):e16023. PubMed ID: 37539836 [TBL] [Abstract][Full Text] [Related]
35. Changes in axonal and clinical function during intravenous and subcutaneous immunoglobulin therapy in chronic inflammatory demyelinating polyneuropathy. Hansen PN; Mohammed AA; Markvardsen LK; Andersen H; Tankisi H; Sindrup SH; Krøigård T J Peripher Nerv Syst; 2023 Sep; 28(3):425-435. PubMed ID: 37212187 [TBL] [Abstract][Full Text] [Related]
36. Successful treatment of relapsed and refractory CIDP with ofatumumab: a first case report. Wang J; Xiang Q Front Immunol; 2024; 15():1437848. PubMed ID: 39144145 [TBL] [Abstract][Full Text] [Related]
37. [Modern aspects of diagnosis and treatment of chronic inflammatory demyelinating polyneuropathy in children]. Kozyreva AA; Bembeeva RT; Druzhinina ES; Zavadenko NN; Kolpakchi LM; Pilia SV Zh Nevrol Psikhiatr Im S S Korsakova; 2024; 124(2):58-68. PubMed ID: 38465811 [TBL] [Abstract][Full Text] [Related]
38. A diagnosis challenge-L4 nerve root compression as the initial presentation of chronic inflammatory demyelinating polyneuropathy. Cojocaru IM; Alexianu M; Bastian A; Sapira V; Herţea C; Cojocaru M Rom J Intern Med; 2012; 50(4):297-308. PubMed ID: 23610977 [TBL] [Abstract][Full Text] [Related]
39. Sialylated IgG-Fc: a novel biomarker of chronic inflammatory demyelinating polyneuropathy. Wong AH; Fukami Y; Sudo M; Kokubun N; Hamada S; Yuki N J Neurol Neurosurg Psychiatry; 2016 Mar; 87(3):275-9. PubMed ID: 25814494 [TBL] [Abstract][Full Text] [Related]
40. Restabilization treatment after intravenous immunoglobulin withdrawal in chronic inflammatory demyelinating polyneuropathy: Results from the pre-randomization phase of the Polyneuropathy And Treatment with Hizentra study. Mielke O; Bril V; Cornblath DR; Lawo JP; van Geloven N; Hartung HP; Lewis RA; Merkies ISJ; Sobue G; Durn B; Shebl A; van Schaik IN; J Peripher Nerv Syst; 2019 Mar; 24(1):72-79. PubMed ID: 30672067 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]